Brief: SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

Neurothera Labs

08/07/2024 13:54

July 8 (Reuters) - Miza III Ventures Inc  MIZAp.V :
    * SCISPARC SIGNS NON-BINDING LETTER OF INTENT FOR SPIN OFF
OF
ADVANCED CLINICAL STAGE PHARMACEUTICAL PORTFOLIO TO PUBLICLY
TRADED COMPANY
    * SCISPARC LTD - ACCORDING TO AGREEMENT, SCISPARC'S
PHARMACEUTICALS ASSETS ARE VALUED AT APPROXIMATELY $11.6 MILLION

Source text for Eikon:  ID:nGNX6Wsplt 
Further company coverage:  MIZAp.V 

 ((Reuters.Briefs@thomsonreuters.com;))